MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Conroy, W. G.
Right arrow Articles by Berg, D. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Conroy, W. G.
Right arrow Articles by Berg, D. K.

Vol. 63, Issue 2, 419-428, February 2003

Potentiation of alpha 7-Containing Nicotinic Acetylcholine Receptors by Select Albumins

William G. Conroy, Qing-Song Liu, Qiang Nai, Joseph F. Margiotta, and Darwin K. Berg

Neurobiology Section, Division of Biological Sciences, University of California, San Diego, La Jolla, California (W.G.C., Q.-S.L., D.K.B.); and Department of Anatomy and Neurobiology; Medical College of Ohio; Toledo, Ohio (Q.N., J.F.M.)

Nicotinic receptors containing alpha 7 subunits are ligand-gated ion channels widely distributed in the nervous system; they influence a diverse array of events because of their high relative calcium permeability. We show here that nicotine-induced whole-cell responses generated by such receptors can be dramatically potentiated in a rapidly reversible manner by some but not all albumins. The potentiation involves increases both in potency and efficacy with no obvious differences in rise and fall times of the response. The potentiation is not reduced by removing absorbed components; it is abolished by proteolysis, suggesting that the albumin protein backbone is essential. The fact that some albumins are ineffective indicates that minor differences in amino acid sequence may be critical. Experiments with open channel blockers indicate that the potentiation involves increased responses from active receptors rather than recruitment of receptors from a previously silent pool. Single channel recordings reveal that the potentiation correlates with increased single channel opening probability, reflected in increased frequency of channel opening and increased mean channel open time. The potentiation can be exploited to overcome blockade by noncompetitive inhibitors such as beta -amyloid peptide. The results raise the possibility that endogenous compounds use the site to modulate receptor function in vivo, and suggest that the receptors may represent useful targets for therapeutic intervention in cases where they have been implicated in neuropathologies such as Alzheimer's disease.


Copyright © 2003 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
D. B. Timmermann, J. H. Gronlien, K. L. Kohlhaas, E. O. Nielsen, E. Dam, T. D. Jorgensen, P. K. Ahring, D. Peters, D. Holst, J. K. Chrsitensen, et al.
An Allosteric Modulator of the {alpha}7 Nicotinic Acetylcholine Receptor Possessing Cognition-Enhancing Properties in Vivo
J. Pharmacol. Exp. Ther., October 1, 2007; 323(1): 294 - 307.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. Halvard Gronlien, M. Hakerud, H. Ween, K. Thorin-Hagene, C. A. Briggs, M. Gopalakrishnan, and J. Malysz
Distinct Profiles of {alpha}7 nAChR Positive Allosteric Modulation Revealed by Structurally Diverse Chemotypes
Mol. Pharmacol., September 1, 2007; 72(3): 715 - 724.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
D. Rayes, G. Spitzmaul, S. M. Sine, and C. Bouzat
Single-Channel Kinetic Analysis of Chimeric {alpha}7-5HT3A Receptors
Mol. Pharmacol., November 1, 2005; 68(5): 1475 - 1483.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
R. S. Hurst, M. Hajos, M. Raggenbass, T. M. Wall, N. R. Higdon, J. A. Lawson, K. L. Rutherford-Root, M. B. Berkenpas, W. E. Hoffmann, D. W. Piotrowski, et al.
A Novel Positive Allosteric Modulator of the {alpha}7 Neuronal Nicotinic Acetylcholine Receptor: In Vitro and In Vivo Characterization
J. Neurosci., April 27, 2005; 25(17): 4396 - 4405.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C.-H. Cho, W. Song, K. Leitzell, E. Teo, A. D. Meleth, M. W. Quick, and R. A. J. Lester
Rapid Upregulation of {alpha}7 Nicotinic Acetylcholine Receptors by Tyrosine Dephosphorylation
J. Neurosci., April 6, 2005; 25(14): 3712 - 3723.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
D. B. Freir and C. E. Herron
Nicotine Enhances the Depressive Actions of A{beta}1-40 on Long-Term Potentiation in the Rat Hippocampal CA1 Region In Vivo
J Neurophysiol, June 1, 2003; 89(6): 2917 - 2922.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics